US Stock MarketDetailed Quotes

Cardiff Oncology (CRDF)

Watchlist
  • 1.690
  • +0.050+3.05%
Close May 13 15:59 ET
  • 1.690
  • 0.0000.00%
Pre 04:00 ET
115.55MMarket Cap-2.45P/E (TTM)

Cardiff Oncology (CRDF) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-0.61%-37.92M
41.88%-5.97M
-3.62%-10.83M
9.77%-8.33M
-65.30%-12.79M
-22.04%-37.69M
-43.82%-10.27M
-31.41%-10.46M
-29.42%-9.23M
10.61%-7.74M
Net income from continuing operations
-0.92%-45.85M
38.78%-7.22M
5.04%-11.26M
-18.38%-13.94M
-34.19%-13.43M
-9.63%-45.43M
-26.24%-11.79M
-21.83%-11.86M
-5.63%-11.78M
10.80%-10.01M
Depreciation and amortization
-4.14%904K
-3.46%223K
-2.18%494K
-41.38%-41K
-3.39%228K
136.93%943K
124.27%231K
371.96%505K
-129.59%-29K
162.22%236K
Change In working capital
-17.24%2.18M
-131.69%-77K
-495.05%-1.2M
180.26%4.27M
-176.48%-816K
-59.91%2.63M
-82.53%243K
-119.75%-202K
-40.91%1.53M
-32.17%1.07M
-Change in receivables
222.11%591K
146.75%72K
262.87%272K
-108.62%-121K
450.48%368K
-200.21%-484K
-71.11%-154K
-351.35%-167K
-111.26%-58K
-210.53%-105K
-Change in prepaid assets
223.23%557K
40.69%-911K
178.35%1.08M
-78.26%172K
327.37%216K
-114.26%-452K
-7,984.21%-1.54M
-58.19%388K
-21.61%791K
-107.59%-95K
-Change in payables and accrued expense
-26.23%2.2M
4.68%940K
-196,000.00%-1.96M
534.18%4.27M
-173.85%-1.05M
5.44%2.99M
-35.99%898K
-100.74%-1K
-38.26%673K
597.04%1.42M
-Change in other current assets
-139.67%-480K
--0
-57.74%-418K
-53.85%126K
-4,800.00%-188K
85.87%1.21M
393.00%1.2M
-292.03%-265K
152.78%273K
-97.53%4K
-Change in other current liabilities
-10.38%-691K
-9.20%-178K
-11.46%-175K
-11.04%-171K
-9.87%-167K
-10.60%-626K
-11.64%-163K
-11.35%-157K
-9.22%-154K
-10.14%-152K
Cash from discontinued investing activities
Operating cash flow
-0.61%-37.92M
41.88%-5.97M
-3.62%-10.83M
9.77%-8.33M
-65.30%-12.79M
-22.04%-37.69M
-43.82%-10.27M
-31.41%-10.46M
-29.42%-9.23M
10.61%-7.74M
Investing cash flow
Cash flow from continuing investing activities
-90.22%1.34M
138.28%10.75M
207.70%10.16M
-135.55%-4.98M
-414.58%-14.58M
-62.07%13.73M
-66.74%4.51M
-346.90%-9.43M
22.04%14.02M
-36.74%4.64M
Capital expenditure reported
45.00%-44K
--0
---18K
---26K
--0
86.25%-80K
--0
--0
--0
-900.00%-80K
Net investment purchase and sale
-89.96%1.39M
138.28%10.75M
207.89%10.18M
-135.37%-4.96M
-409.25%-14.58M
-62.45%13.81M
-66.76%4.51M
-328.09%-9.43M
19.43%14.02M
-35.72%4.72M
Cash from discontinued investing activities
Investing cash flow
-90.22%1.34M
138.28%10.75M
207.70%10.16M
-135.55%-4.98M
-414.58%-14.58M
-62.07%13.73M
-66.74%4.51M
-346.90%-9.43M
22.04%14.02M
-36.74%4.64M
Financing cash flow
Cash flow from continuing financing activities
-95.20%2.58M
-94.22%2.55M
-99.66%25K
0
-97.20%3K
53.78M
44.19M
7.43M
2.06M
107K
Net common stock issuance
--0
--0
--0
----
----
--53.41M
--44.18M
--7.43M
----
----
Proceeds from stock option exercised by employees
591.96%2.58M
19,538.46%2.55M
--25K
--0
-97.20%3K
--373K
--13K
--0
--253K
--107K
Cash from discontinued financing activities
Financing cash flow
-95.20%2.58M
-94.22%2.55M
-99.66%25K
--0
-97.20%3K
--53.78M
--44.19M
--7.43M
--2.06M
--107K
Net cash flow
Beginning cash position
137.68%51.47M
-22.27%10.14M
-57.71%10.78M
29.14%24.1M
137.68%51.47M
32.47%21.66M
-14.41%13.04M
31.66%25.5M
24.25%18.66M
32.47%21.66M
Current changes in cash
-214.04%-34M
-80.91%7.34M
94.79%-649K
-294.52%-13.31M
-813.41%-27.38M
461.70%29.82M
498.44%38.43M
-201.33%-12.46M
57.24%6.84M
-125.34%-3M
End cash Position
-66.06%17.47M
-66.06%17.47M
-22.27%10.14M
-57.71%10.78M
29.14%24.1M
137.68%51.47M
137.68%51.47M
-14.41%13.04M
31.66%25.5M
24.25%18.66M
Free cash flow
-0.51%-37.97M
41.88%-5.97M
-3.79%-10.85M
9.49%-8.35M
-63.61%-12.79M
-20.03%-37.77M
-43.65%-10.27M
-26.40%-10.46M
-25.02%-9.23M
9.77%-7.82M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -0.61%-37.92M41.88%-5.97M-3.62%-10.83M9.77%-8.33M-65.30%-12.79M-22.04%-37.69M-43.82%-10.27M-31.41%-10.46M-29.42%-9.23M10.61%-7.74M
Net income from continuing operations -0.92%-45.85M38.78%-7.22M5.04%-11.26M-18.38%-13.94M-34.19%-13.43M-9.63%-45.43M-26.24%-11.79M-21.83%-11.86M-5.63%-11.78M10.80%-10.01M
Depreciation and amortization -4.14%904K-3.46%223K-2.18%494K-41.38%-41K-3.39%228K136.93%943K124.27%231K371.96%505K-129.59%-29K162.22%236K
Change In working capital -17.24%2.18M-131.69%-77K-495.05%-1.2M180.26%4.27M-176.48%-816K-59.91%2.63M-82.53%243K-119.75%-202K-40.91%1.53M-32.17%1.07M
-Change in receivables 222.11%591K146.75%72K262.87%272K-108.62%-121K450.48%368K-200.21%-484K-71.11%-154K-351.35%-167K-111.26%-58K-210.53%-105K
-Change in prepaid assets 223.23%557K40.69%-911K178.35%1.08M-78.26%172K327.37%216K-114.26%-452K-7,984.21%-1.54M-58.19%388K-21.61%791K-107.59%-95K
-Change in payables and accrued expense -26.23%2.2M4.68%940K-196,000.00%-1.96M534.18%4.27M-173.85%-1.05M5.44%2.99M-35.99%898K-100.74%-1K-38.26%673K597.04%1.42M
-Change in other current assets -139.67%-480K--0-57.74%-418K-53.85%126K-4,800.00%-188K85.87%1.21M393.00%1.2M-292.03%-265K152.78%273K-97.53%4K
-Change in other current liabilities -10.38%-691K-9.20%-178K-11.46%-175K-11.04%-171K-9.87%-167K-10.60%-626K-11.64%-163K-11.35%-157K-9.22%-154K-10.14%-152K
Cash from discontinued investing activities
Operating cash flow -0.61%-37.92M41.88%-5.97M-3.62%-10.83M9.77%-8.33M-65.30%-12.79M-22.04%-37.69M-43.82%-10.27M-31.41%-10.46M-29.42%-9.23M10.61%-7.74M
Investing cash flow
Cash flow from continuing investing activities -90.22%1.34M138.28%10.75M207.70%10.16M-135.55%-4.98M-414.58%-14.58M-62.07%13.73M-66.74%4.51M-346.90%-9.43M22.04%14.02M-36.74%4.64M
Capital expenditure reported 45.00%-44K--0---18K---26K--086.25%-80K--0--0--0-900.00%-80K
Net investment purchase and sale -89.96%1.39M138.28%10.75M207.89%10.18M-135.37%-4.96M-409.25%-14.58M-62.45%13.81M-66.76%4.51M-328.09%-9.43M19.43%14.02M-35.72%4.72M
Cash from discontinued investing activities
Investing cash flow -90.22%1.34M138.28%10.75M207.70%10.16M-135.55%-4.98M-414.58%-14.58M-62.07%13.73M-66.74%4.51M-346.90%-9.43M22.04%14.02M-36.74%4.64M
Financing cash flow
Cash flow from continuing financing activities -95.20%2.58M-94.22%2.55M-99.66%25K0-97.20%3K53.78M44.19M7.43M2.06M107K
Net common stock issuance --0--0--0----------53.41M--44.18M--7.43M--------
Proceeds from stock option exercised by employees 591.96%2.58M19,538.46%2.55M--25K--0-97.20%3K--373K--13K--0--253K--107K
Cash from discontinued financing activities
Financing cash flow -95.20%2.58M-94.22%2.55M-99.66%25K--0-97.20%3K--53.78M--44.19M--7.43M--2.06M--107K
Net cash flow
Beginning cash position 137.68%51.47M-22.27%10.14M-57.71%10.78M29.14%24.1M137.68%51.47M32.47%21.66M-14.41%13.04M31.66%25.5M24.25%18.66M32.47%21.66M
Current changes in cash -214.04%-34M-80.91%7.34M94.79%-649K-294.52%-13.31M-813.41%-27.38M461.70%29.82M498.44%38.43M-201.33%-12.46M57.24%6.84M-125.34%-3M
End cash Position -66.06%17.47M-66.06%17.47M-22.27%10.14M-57.71%10.78M29.14%24.1M137.68%51.47M137.68%51.47M-14.41%13.04M31.66%25.5M24.25%18.66M
Free cash flow -0.51%-37.97M41.88%-5.97M-3.79%-10.85M9.49%-8.35M-63.61%-12.79M-20.03%-37.77M-43.65%-10.27M-26.40%-10.46M-25.02%-9.23M9.77%-7.82M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More